Alexion Pharmaceuticals Board Approves $1 Billion Buyback
24 October 2019 - 12:19AM
Dow Jones News
By Colin Kellaher
Alexion Pharmaceuticals Inc. (ALXN) on Wednesday said its board
authorized the repurchase of up to $1 billion in stock.
The Boston biopharmaceutical company said it has no obligation
to buy back any particular number of shares under the program,
which has no expiration date.
Alexion, which has about 224 million shares outstanding, sports
a market capitalization of roughly $22.26 billion based on
Tuesday's closing price of $99.28.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 23, 2019 09:04 ET (13:04 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2024 to May 2024
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Alexion Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Alexion Pharmaceuticals Inc News Articles